Doxycycline

Treatment for Gonorrhea

Typical Dosage: 100 mg orally twice daily for 7 days

Effectiveness
95%
Safety Score
70%
Clinical Trials
9
Participants
50K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
70
DangerousModerateSafe
Treatment Details
Dosage Range
100 mg orally twice daily for 7 days
Time to Effect
Days
Treatment Duration
7 days
Evidence Quality
HIGH
Number Needed to Treat (NNT)
1(Treat 1 patients to see 1 additional successful outcome)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$15
Monitoring:$300
Side Effect Mgmt:$5
Total Annual:$320
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.05
Outcome-Based Costs
Cost per Responder
$336.84
Cost per Remission
$336.84
Prescription Access Economics
Annual Societal Loss per Patient
$355
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$300/year
Time Cost
$60/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$15/year
Potential OTC Price
$40/year
Estimated if OTC available
Early Treatment Benefit
+0.05 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOW
Missed Diagnosis Risk
MODERATE
Doxycycline Outcomes

for Gonorrhea

Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+95%
Remission Rate
+95%
Common Side Effects
GI upset (nausea, vomiting, diarrhea)
+15%
Photosensitivity
+10%
Esophageal irritation/ulceration
+1%
Vaginal candidiasis
+5%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
6 active trials recruiting for Doxycycline in Gonorrhea

The Efficacy of Doxycycline Post Exposure Prophylaxis for Preventing STIs Among MSM in Bangkok, Thailand.

NCT07397403RECRUITINGPHASE4
View Study
400 participants
INTERVENTIONAL
Sathorn, Thailand
Started: Oct 6, 2025

Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro

NCT07500415RECRUITINGNA
View Study
200 participants
INTERVENTIONAL
Rio de Janeiro, Brazil
Started: Oct 28, 2025

Superiority of On-demand PrEP Versus PEP on Using Doxycycline for Preventing STI in MSM

NCT06188442RECRUITINGPHASE4
View Study
300 participants
INTERVENTIONAL
Shatin, Hong Kong
Started: Mar 29, 2025

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections

NCT06738407NOT YET RECRUITINGPHASE4
View Study
760 participants
INTERVENTIONAL
Los Angeles, United States +11 more
Started: Jan 5, 2026

Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM

NCT06468462RECRUITINGPHASE4
View Study
2.9K participants
INTERVENTIONAL
Kisumu, Kenya +2 more
Started: Oct 29, 2025

Improving Clinic Delivery of HIV-related Anal Health Services

NCT07464236NOT YET RECRUITINGNA
View Study
8 participants
INTERVENTIONAL
Biloxi, United States
Started: May 1, 2026
Completed Clinical Trials
5 completed trials for Doxycycline in Gonorrhea

Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea

NCT06090565COMPLETEDPHASE4
View Study
161 participants
INTERVENTIONAL
Prague, Czechia +1 more
Started: Apr 1, 2021

Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men

NCT03980223COMPLETEDPHASE4
View Study
641 participants
INTERVENTIONAL
San Francisco, United States +2 more
Started: Nov 26, 2019

Comparison of Efficacy of Two Combination Regimens for the Neisseria Gonorrhoeae and Chlamydia Coinfection

NCT05216744COMPLETEDPHASE2
View Study
125 participants
INTERVENTIONAL
Haiphong, Vietnam
Started: Jul 15, 2021

Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP

NCT04050540COMPLETEDPHASE4
View Study
449 participants
INTERVENTIONAL
Kisumu, Kenya
Started: Feb 5, 2020

NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)

NCT00322465COMPLETEDPHASE2
View Study
305 participants
INTERVENTIONAL
Birmingham, United States +3 more
Started: Nov 1, 2006